MAPT and Alzheimer disease: Most importantly, both single and multiple doses (once per 6 days for a total of five times) of subcutaneous degrader 240 (C004019) significantly reduced tau levels in the brains of wild-type, hTau-transgenic, and 3xTg-AD mice with improved synaptic and cognitive function.